Meteora Capital’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-82,940
Closed -$1.9K 409
2023
Q3
$1.9K Hold
82,940
﹤0.01% 311
2023
Q2
$1.79K Hold
82,940
﹤0.01% 333
2023
Q1
$1.24K Buy
82,940
+2,500
+3% +$73 ﹤0.01% 396
2022
Q4
$4.02K Buy
+80,440
New +$4.41K ﹤0.01% 271

Other funds holding VHAQ.WS

Meteora Capital's VHAQ.WS Position: Q4 2023 in Review

Meteora Capital sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 82,940 shares — an estimated $1.9K sold.

Meteora Capital first reported a position in VHAQ.WS in Q4 2022 and held it in 4 quarters. The position peaked at $4.02K in Q4 2022. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.

  • Meteora Capital reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
  • Meteora Capital sold 82,940 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $1.9K.
  • Meteora Capital first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q4 2022 and held it in 4 quarters.
  • Meteora Capital's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $4.02K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.

Based on Meteora Capital's 13F filing for Q4 2023, filed 14 Feb 2024.